This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by SPIEKERMAN, R. E. Articles by MCGUCKIN, W. F. Search for Related Content PubMed PubMed Citation Articles by SPIEKERMAN, R. E. Articles by MCGUCKIN, W. F.

(Circulation. 1966;34:524.)
© 1966 American Heart Association, Inc.

---

Potassium-Sparing Effects of Triamterene in the Treatment of Hypertension

RALPH E. SPIEKERMAN M.D.¹; KENNETH G. BERGE M.D.¹; DELORAN L. THURBER M.D.¹; STAFFORD W. GEDGE M.D.¹; WARREN F. MCGUCKIN PH.D.¹

¹ From the Mayo Clinic and Mayo Foundation, Rochester, Minnesota.

Triamterene (2,4,7-triamino-6-phenylpteridine) was employed alone and in combination with hydrochlorothiazide in the treatment of patients with group 1 and 2 hypertension. In 21 patients, triamterene alone had an inconsistent antihypertensive effect on the systolic blood pressure, which was minimal in most patients. In 16 patients the combination of triamterene and hydrochlorothiazide (2:1 by weight) reduced the systolic blood pressure slightly more than did hydrochlorothiazide alone. Triamterene alone or in combination with hydrochlorothiazide produced an increase in the concentration of potassium in serum. Side effects due to triamterene were similar to those noted with thiazide diuretics. In addition, five patients had a decrease in blood hemoglobin concentration, and two patients had reversible alterations in liver function during triamterene therapy. Triamterene may be a useful adjunct for thiazidetreated hypertensive patients by decreasing the likelihood of complicating hypokalemia.